Asia-Pacific
The model covers court-guided settlements, submissions-led determination of infringement and validity issues, and leeway for the court to determine a FRAND rate during negotiations
Pantech counsel Shogo Matsunaga speaks exclusively to Managing IP about how his team proved Google’s unwillingness, and ultimately secured a landmark SEP settlement
Chunguang Hu of China PAT explains why his ‘insider’ experience as a patent examiner benefits clients and why he wants to debunk the myth that IP has limited value in China
Essenese Obhan shares his expansion plans and vision of creating a ‘one-stop shop’ for clients after Indian firms Obhan & Associates and Mason & Associates joined forces
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Hechanova GroupEditha R Hechanova of Hechanova Group summarises the common issues and rewards of mediating intellectual property and other disputes in the Philippines based on her extensive experience -
Sponsored by Anand and AnandPravin Anand and Ashutosh Upadhyaya of Anand and Anand examine whether taste can function as a trademark in India, with insights drawn from international practice and examples of graphical representations
-
Sponsored by That.LegalGillian Tan of That.Legal explains Singapore’s approach to goodwill in passing off and what two recent cases mean for pre-launch market entry
-
Sponsored by Tilleke & GibbinsKhin Yadanar Htay and Khin Myo Myo Aye of Tilleke & Gibbins summarise Myanmar’s new Geographical Indication Rules, covering application procedures, local representation requirements, and GI logo authorisation for domestic and international applicants
-
Sponsored by Tilleke & GibbinsProactive measures are needed to counteract opportunistic bad-faith actors, say Diep Thi Bich Le and Hang Thi Thanh Phan of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains how a ruling has rejected attempts to limit protection to initially approved drug indications
